Healthcare Stocks
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1041 |  OCS Oculis Holding AG Ordinary shares | 27.04 USD | -1.82% | -1.31% | +3.96% | +49.23% | 0 USD | ||
| 1042 |  AZN AstraZeneca PLC | 200.71 USD | -0.30% | -2.63% | +3.56% | +198.72% | 0 USD | ||
| 1043 |  ANL Adlai Nortye Ltd. American Depositary Shares | 14.04 USD | +5.96% | +18.28% | +86.21% | +671.43% | 0 USD | ||
| 1044 |  GRFS Grifois, S.A. | 8.57 USD | -1.38% | +6.46% | +6.86% | +22.25% | 0 USD | ||
| 1045 |  NVO Novo-Nordisk A/S | 40.86 USD | +0.12% | +8.70% | +5.66% | -29.28% | 0 USD | ||
| 1046 |  SXTC China SXT Pharmaceuticals, Inc. Class A Ordinary Shares | 1.95 USD | +3.72% | -6.25% | +7.14% | +80.56% | 0 USD | ||
| 1047 |  CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.0914 USD | +14.82% | +14.25% | -34.01% | +103.11% | 0 USD | ||
| 1048 |  YDES YD Bio Limited Ordinary Shares | 5.21 USD | -4.05% | -11.09% | -31.98% | -34.88% | 0 USD | ||
| 1049 |  AGMB AgomAb Therapeutics NV American Depositary Shares | 11.2400 USD | +5.44% | +10.36% | -21.34% | -23.54% | 0 USD | ||
| 1050 |  EIKN Eikon Therapeutics, Inc. Common Stock | 11.46 USD | +5.72% | +22.44% | -3.62% | -32.79% | 0 USD | ||
| 1051 |  PARK Park Dental Partners, Inc. Common Stock | 18.38 USD | +0.99% | +1.16% | +6.92% | +41.38% | 0 USD | ||
| 1052 |  LMRI Lumexa Imaging Holdings, Inc. Common Stock | 9.1700 USD | -3.78% | -2.55% | -30.32% | -50.83% | 0 USD | ||
| 1053 |  ADAP Adaptimmune Therapeutics PLC | 0.05 USD | -16.67% | 0.00% | -61.54% | -91.38% | 0 USD | ||
| 1054 |  AADI Whitehawk Therapeutics, Inc. | 2.05 USD | -2.38% | 0.00% | -19.29% | -27.30% | 0 USD | ||
| 1055 |  RVMDW Revolution Medicines, Inc. Common Stock | 5.5600 USD | -6.55% | +200.54% | +206.34% | +8453.85% | 29.75 B USD | ||
| 1056 |  BTSGU BrightSpring Health Services, Inc. Common Stock | 153.2900 USD | +0.42% | +0.02% | +15.95% | +155.48% | 8.89 B USD | ||
| 1057 |  BRKRP Bruker Corporation | 306.1800 USD | -1.32% | +1.57% | +12.41% | +18.67% | 6.02 B USD | ||
| 1058 |  NAMSW NewAmsterdam Pharma Company N.V. Ordinary Shares | 23.4000 USD | -0.43% | +6.27% | +30.00% | +254.55% | 3.85 B USD | ||
| 1059 |  SLXNW Silexion Therapeutics Corp Ordinary Shares | 0.0280 USD | +3.70% | +115.38% | +63.74% | -44.55% | 3.43 B USD | ||
| 1060 |  WGSWW GeneDx Holdings Corp. Class A Common Stock | 0.0074 USD | 0.00% | +12.12% | +23.33% | -94.81% | 1.95 B USD |
Nouvelles Healthcare Stocks
Abbott Laboratories: This Dividend Growth King Has Rarely Been So Cheap (NYSE:ABT)
Leerink maintient sa note Market Perform sur Abbott Labs
Meitav Investment House lance une offre publique d’achat sur Peninsula
Immunic, Inc. (IMUX) Presents at 8th Annual Neuroimmunology Drug Development Summit - Slideshow (NASDAQ:IMUX) 2026-04-16
L’action d’Amylyx Pharmaceuticals atteint un sommet de 52 semaines à 17,5 $
Xilio Therapeutics nomme Cheryl Blanchard à son conseil d’administration
Inspira Technologies livre un système de fabrication à un site de défense américain
Gainers Healthcare Stocks
 NMTC NeuroOne Medical Technologies Corporation Common Stock | 4.57 | +517.57% |
 SCLXW Scilex Holding Company Common Stock | 0.1096 | +67.84% |
 IOBT IO Biotech, Inc. Common Stock | 0.05 | +66.67% |
 TALKW Talkspace, Inc. Common Stock | 0.0028 | +64.71% |
 EUDAW EUDA Health Holdings Limited Ordinary Shares | 0.0348 | +50.00% |
 NIVFW NewGenIvf Group Limited Class A ordinary shares | 0.0194 | +45.86% |
 CDTTW CDT Equity Inc. Common Stock | 0.0085 | +41.67% |
 ACHV Achieve Life Sciences, Inc. | 4.99 | +40.56% |
Losers Healthcare Stocks
 HUMAW Humacyte, Inc. Common Stock | 0.0600 | -31.74% |
 QDEL QuidelOrtho Corporation Common Stock | 11.9900 | -31.45% |
 WORX SC WORX Corp | 1.06 | -30.72% |
 ERNAW Ernexa Therapeutics Inc. Common Stock | 0.0350 | -29.86% |
 CINGW Cingulate Inc. Common Stock | 0.0155 | -26.19% |
 ASBP Aspire Biopharma Holdings, Inc. Common Stock | 0.4125 | -24.30% |
 COCHW Envoy Medical, Inc. Class A Common Stock | 0.0500 | -23.08% |
 VVOS Vivos Therapeutics, Inc. Common Stock | 1.14 | -22.45% |